These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4591149)

  • 1. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
    Persson I; Ulrich J
    Eur J Clin Pharmacol; 1973 Dec; 6(4):217-9. PubMed ID: 4591149
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 6. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
    Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 12. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of coexistent angina pectoris and hypertension with prindolol.
    Leary WP; Asmal AC
    S Afr Med J; 1975 Jan; 49(1):11-2. PubMed ID: 803324
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 17. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pindolol, a beta receptor antagonist, in hyperthyroidism.
    Schelling JL; Scazziga B; Dufour RJ; Milinkovic N; Weber AA
    Clin Pharmacol Ther; 1973; 14(2):158-64. PubMed ID: 4695378
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.